Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Oct 16, 2010
When a new project is initiated at Chr. Hansen, our scientists take the project through the value chain from idea to market.
When a project is defined and the desired claims are decided on, our work starts in the Chr. Hansen Culture Collection, from which selected strains undergo two screenings. The first screening selects the strains that live up to the general high quality demands of Chr. Hansen. The strains approved here, moves on to the second screening, where we test for the strain abilities necessary for the specific project. The effect you want your product to have!
The strains then move into pre-clinical and clinical trials, and our scientists start working on developing the right application for the final product. At this point we have a good indication that our project will succeed.
A process for production is developed, taking into account the safety requirements we have for all of our probiotic products. While this is underway, the product moves into the final test: The human clinical studies. All of our products are proven efficient when ingested by humans.
After successful human studies, our product is approved and production is underway -- a new Chr. Hansen product type is ready for the market!